- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01683643
Screening, Brief Intervention, and Referral to Treatment for Offenders (SBIRT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an evidence-based practice that has been found to be effective in reducing alcohol and illicit drug use, mainly among persons recruited in medical centers, primary care offices, emergency rooms, and colleges and universities. But SBIRT has the potential to be applicable to other populations that have, or that are at risk for, substance use problems. In particular, offenders have high prevalence of drug and alcohol use at varying levels of severity and often do not receive adequate intervention, either because of limited availability of programs, low motivation, or lack of awareness of the consequences of their substance use.
The scientific aims of the study are:
- Assess the effectiveness of SBIRT with offenders in terms of participation in brief intervention (if so indicated) and enrollment in treatment (if so indicated).
- Assess the effectiveness of SBIRT with offenders in terms of drug use, criminal activity, and criminal justice involvement at 12 months following baseline.
- Determine whether there are differences in acceptability, participation, and outcomes between men and women.
- Determine the cost of providing the SBIRT intervention with this population.
The clinical aims of the study are:
- To complement the use of SBIRT within Los Angeles County's substance abuse treatment system.
- To expand prevention and treatment options for offenders with substance abuse problems.
To our knowledge, this would be the first rigorous test of SBIRT with an offender population.
We will recruit inmates at two Los Angeles County Sheriff jail facilities, one for men and one for women (25% of total sample), and randomly assign them to the treatment (SBIRT) group (N =400) or to the control (no intervention) group (N = 400). Baseline demographic data will be collected. Subjects in both groups will be screened for substance use risk using The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization. Control subjects will receive only their risk score and informational materials regarding the health risks of substance use. Experimental subjects, in addition to their risk score and informational materials, will also receive a brief intervention and a referral to treatment appropriate to their risk score from trained health educators. The health educators will be provided by Homeless Health Care, Los Angeles. Twelve months after study admission, all study participants will be contacted for a follow-up interview. We will obtain records-based data on arrests and jail incarceration over the follow-up period from the Sheriff's Department and the California Department of Justice. We will also collect subject participation in publicly-funded treatment from the Substance Abuse Prevention and Control Division of the Los Angeles County Department of Health.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90025
- University of California
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
The sample for the study will be drawn from an offender population who are within 2-3 weeks of their release from MCJ or CRDF in Los Angeles County. In addition, subjects must be:
- At least 18 years of age
- English or Spanish speaking
- Not subject to extended jail or prison sentence
- Able to provide informed consent to participate in the study
Exclusion Criteria:
Study exclusion criteria:
- Inability to provide informed consent to study participation because of cognitive impairment.
- Inability to communicate in either English or Spanish
- Refusal to complete Locator form for follow-up.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SBIRT Group
Baseline demographic data will be collected.
Subjects will be screened for substance use risk using The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization.
Experimental subjects, in addition to their risk score and informational materials, will also receive a brief intervention and a referral to treatment appropriate to their risk score from trained health educators.
The health educators will be provided by Homeless Health Care, Los Angeles.
|
Screening, brief intervention, and referral to treatment.
|
|
Active Comparator: Control Group
Baseline demographic data will be collected.
Subjects will be screened for substance use risk using The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization.
Control subjects will receive only their risk score and informational materials regarding the health risks of substance use.
|
Control subjects will receive only their risk score and informational materials regarding the health risks of substance use.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
A reduction in the use of drugs and alcohol
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quality of life
Time Frame: 12 months
|
12 months
|
|
Participation in treatment
Time Frame: 12 months
|
12 months
|
|
Rearrest and incarceration
Time Frame: 12 months
|
12 months
|
|
A reduction in HIV risk behaviors
Time Frame: 12 months
|
12 months
|
|
The cost benefit of SBIRT for offenders
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Michael Prendergast, Ph.D, UCLA Integrated Substance Abuse Programs
- Study Director: Jerry Cartier, M.A., UCLA Integrated Substance Abuse Programs
Publications and helpful links
General Publications
- Prendergast ML, McCollister K, Warda U. A randomized study of the use of screening, brief intervention, and referral to treatment (SBIRT) for drug and alcohol use with jail inmates. J Subst Abuse Treat. 2017 Mar;74:54-64. doi: 10.1016/j.jsat.2016.12.011. Epub 2016 Dec 30.
- Prendergast ML, Cartier JJ. Screening, brief intervention, and referral to treatment (SBIRT) for offenders: protocol for a pragmatic randomized trial. Addict Sci Clin Pract. 2013 Oct 23;8(1):16. doi: 10.1186/1940-0640-8-16.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01DA031879 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CAN Community HealthGilead Sciences; Midway Specialty Care Center; Costello Medical Inc.Not yet recruitingHIV | HIV 1 Infection | HIV -1 Infection | HIV (Human Immunodeficiency Virus)United States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV Infections | HIV SeronegativityUnited States, Puerto Rico
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
Clinical Trials on SBIRT
-
Treatment Research InstitutePennsylvania Department of HealthCompletedAlcohol Use | Drug UseUnited States
-
University of Colorado, DenverNational Institute of Mental Health (NIMH); Washington State University; University...RecruitingSuicide PreventionUnited States
-
VA Office of Research and DevelopmentYale UniversityCompletedAttendance at Treatment | PTSD, Substance Use, and Attendance at TreatmentUnited States
-
University of Central FloridaFlorida International UniversityCompletedTransgender Women | Hiv | Substance AbuseUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA); US Department of Veterans Affairs; National...Completed
-
Yale UniversityNational Institute on Drug Abuse (NIDA); US Department of Veterans Affairs; National...Completed
-
Yale UniversityNational Center for Complementary and Integrative Health (NCCIH)Completed
-
University of Maryland, BaltimoreCompleted
-
Chestnut Health SystemsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedSubstance Use DisordersUnited States
-
Children's Hospital Medical Center, CincinnatiEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedSmoking CessationUnited States